Topic
obesity-drugs
2 stories related to this topic, newest first.
medpagetoday.comhealth1 day agoDeveloping
GLP-1 Obesity Drugs Surpass Oncology in Pharmaceutical R&D Returns
Obesity treatments have become the leading driver of pharmaceutical research and development gains, surpassing oncology. A Deloitte partner highlighted concentration risks for companies reliant on these drugs. Plus-size model Ashley Graham described the trend as disheartening for…
Kavali Chandrakanth KCK / Wikimedia (CC BY-SA 4.0)science5 days agoDeveloping
Eli Lilly Reports Strong Q1 2026 Earnings and Raises Full-Year Guidance
Eli Lilly reported first-quarter 2026 earnings and revenue that exceeded analyst estimates, driven by sales of its drugs Zepbound and Mounjaro. The company raised its full-year sales outlook by $2 billion and increased its adjusted profit guidance. Demand for these treatments con…